Venue Phone: 833-530-7596

1801 N. Glenville Drive, Richardson, Texas, 75081, United States

Study Details:

The objective of this study is to assess the effectiveness an anti-aging serum. During the study you will be required to have your blood drawn to test for blood-borne pathogens, HIV, and Hepatitis B and C.  You will also be required to have two 2mm biopsies (one at baseline and one at the final visit) on the side of your face near your hair line at eye level.

Compensation: You may be compensated up to $850 for time and travel.


Gender Age Fitzpatrick Skin type Break Period
Females 43-75 I-VI Determine your Fitzpatrick Skin Type Here! 1 month from a study involving the face, neck décolletage or eye area

 Inclusion Criteria:

  • Currently a nonsmoker.
  • Mild to moderate fine lines, wrinkles, wrinkled skin that looks like crepe paper and loose skin on the face and décolletage.
  • Having normal/dry to dry skin.
  • Having concerns about aging skin on the face and décolletage (upper chest).
  • Willing to have two 2-mm punch biopsies taken from the face.
  • Willing to have blood drawn to screen for blood-borne pathogens (BBP) including human immunodeficiency virus (HIV), hepatitis B (HBV), and hepatitis C (HCV).
  • Having not had any facial treatments in the past 6 months and are willing to withhold all facial treatments during the course of the study including facials, facial peels, photo facials, laser treatments, dermabrasion, botulinum toxin (Botox®), injectable filler treatments, intense pulsed light (IPL), acid treatments, tightening treatments, facial plastic surgery, or any other treatment administered by a physician or skin care professional designed to improve the appearance or firmness of facial skin. Threading is allowed but not waxing or facial laser hair removal.


Exclusion Criteria

  • Currently participating in any other clinical trial at Stephens, another research facility, or doctor’s office.
  • Having any of the following eye conditions: glaucoma or other condition or disease of the eyes, acute or chronic ocular diseases, dry eyes, prosthetic eye
  • Having had eye surgery in the last 3 years.
  • Having an ocular disease or condition or abnormal/excessive tearing or currently using a prescription eye medication or other ophthalmic preparations.
  • Reporting subjective eye irritation, including stinging, burning, itching, dryness, pain, and/or foreign body sensation.
  • Having active allergic rhinitis or seasonal allergies that result in eye inflammation.
  • Having corneal defects or clinically significant eye irritation.
  • Currently taking or have taken:
  1. Oral isotretinoin (Accutane®) within the last year
  2. Prescription-strength retinoids such as Avita®, Differin®, Renova®, Retin-A®, Retin-A Micro®, Soriatane®, or Tazorac® within 3 months
  3. Prescription-strength skin-lightening products (eg, hydroquinone, tretinoin, alpha/beta/poly-hydroxy acids, 4-hydroxyanisole alone or in combination with tretinoin, etc) within 3 months.
  4. Any anti-wrinkle, skin-firming, or other product or topical or systemic medication or supplements or nutricosmetics known to affect skin aging (eg, products containing alpha/beta/poly-hydroxy acids, CoQ-10, retinol, retinaldehyde, retinyl esters, soy, vitamin C [topically], BioSil, IMEDEEN, Aethern) within 2 weeks.
  • Having a health condition and/or pre-existing or dormant dermatologic disease on the face, neck, or décolletage (eg, psoriasis, rosacea, acne [moderate to severe acne, acne conglobata, nodules, or cysts], eczema, seborrheic dermatitis, severe excoriations).
  • Currently using or having regularly used corticosteroids (systemic or topical, not nasal or ocular) within the past 4 weeks (including but not limited to betamethasone, clobetasol, desoximetasone, diflorasone, fluocinonide, fluticasone, mometasone, halcinonide, and halobetasol).
  • Having a disease such as asthma, diabetes, epilepsy, hypertension, hyperthyroidism, or hypothyroidism that is not controlled by diet or medication. Individuals having multiple health conditions may be excluded from participation even if the conditions are controlled by diet, medication, etc.
  • Having a medical history of allergy, hypersensitivity, or any serious reaction to local antibiotic, antiseptic, or local anesthesia (such as lidocaine or prilocaine), or having any treatment which may affect the blood coagulation and hemostasis (anti-coagulant medications, including Coumadin, Heparin, Plavix, chronic NSAID use, etc.).
  • Having a history of developing abnormal pigmentation responses (skin color changes) such as hyperpigmentation or hypopigmentation from medical procedures such as surgical incision and skin biopsies, or a history of healing defects such as hypertrophy or keloid scarring.
  • Currently or frequently using anti-inflammatory medication for a defined medication condition. Low dose aspirin (≤81 mg per day) is acceptable.
  • Having a history of tuberculosis or other systemic granulomatous diseases (active or inactive) or connective tissue diseases (eg lupus, dermatomyositis).
  • Having been diagnosed with hepatitis, acute or chronic renal insufficiency.


Click Here to see standard requirements for All Stephens Studies!


  • Click Continue to Apply!
    July 29, 2019 - August 28, 2019
    8:00 am - 5:00 pm
Click Continue to Apply!

Online event registration and ticketing powered by Event Espresso